By Priyanjana Pramanik, MSc. A massive nationwide study shows that lighting up before age 20 leaves a lasting cardiovascular ...

Sotagliflozin, a dual SGLT1/2 inhibitor, shows benefit specifically for reducing myocardial infarction and stroke risks. Among patients with type 2 diabetes and chronic kidney disease (CKD) at ...

Some patients with an acute large-vessel ischemic stroke who already show a large-core infarct at early imaging can still benefit from thrombectomy, especially if the procedure successfully restores ...

After nonfatal myocardial infarction or stroke, initiation of a GLP-1 receptor agonist was linked to reduced risk for all-cause and CV-related mortality in patients with diabetes, researchers reported ...

Analysis of the FOURIER trial shows that evolocumab provides greater MACE risk reduction in patients with higher BMI and stable ASCVD.

An episode of shingles, caused by the herpes zoster virus, temporarily increases the risk for stroke and potentially myocardial infarction (MI) in the months after the infection, according to two ...

A secondary analysis of the phase 2 PACIFIC-STROKE trial showed that asundexian is effective for the secondary prevention of stroke in patients with stroke of atherosclerotic origin, but not those ...

The artery of Percheron (AOP) represents a rare anatomical variant whereby a single arterial trunk supplies both paramedian thalami and, in many cases, the rostral midbrain. Occlusion of this artery ...